A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease. uri icon

authors

  • Galasko, Douglas
  • Pa, Judy
  • Aslanyan, Vahan
  • Balasubramanian, Archana
  • West, Tim
  • Maccecchini, Maria
  • Feldman, Howard H
  • Farlow, Martin R
  • Brendan Lucey, MD, MSCI
  • Honig, Lawrence S
  • Elbert, Donald
  • Bateman, Randall
  • Momper, Jeremiah
  • Thomas, Ronald G
  • Rissman, Robert A

publication date

  • July 5, 2024